168 related articles for article (PubMed ID: 37103624)
1. A diagnostic model based on color vision examination for dysthyroid optic neuropathy using Hardy-Rand-Rittler color plates.
Liang J; Tian P; Wang J; Fan S; Deng X; Zhang J; Zhang J; Wang M; Zeng P
Graefes Arch Clin Exp Ophthalmol; 2023 Sep; 261(9):2669-2678. PubMed ID: 37103624
[TBL] [Abstract][Full Text] [Related]
2. Comparison between Hardy-Rand-Rittler 4th edition and Ishihara color plate tests for detection of dyschromatopsia in optic neuropathy.
Huna-Baron R; Glovinsky Y; Habot-Wilner Z
Graefes Arch Clin Exp Ophthalmol; 2013 Feb; 251(2):585-9. PubMed ID: 22688625
[TBL] [Abstract][Full Text] [Related]
3. Subclinical dysthyroid optic neuropathy: tritan deficiency as an early sign of dysthyroid optic neuropathy.
Garip-Kuebler A; Halfter K; Reznicek L; Klingenstein A; Priglinger S; Hintschich CR
Br J Ophthalmol; 2021 Jul; 105(7):1019-1023. PubMed ID: 32699051
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of Hardy-Rand-Rittler and Ishihara colour plates for the diagnosis of nonglaucomatous optic neuropathy.
Aroichane M; Pieramici DJ; Miller NR; Vitale S
Can J Ophthalmol; 1996 Dec; 31(7):350-5. PubMed ID: 8971455
[TBL] [Abstract][Full Text] [Related]
5. Visual function changes of dysthyroid optic neuropathy and ROC curve analysis for early diagnostic indicators.
Wang S; Wang J; Chen L; Tan J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 48(8):1197-1202. PubMed ID: 37875359
[TBL] [Abstract][Full Text] [Related]
6. Identification of red-green colour deficiency: sensitivity of the Ishihara and American Optical Company (Hard, Rand and Rittler) pseudo-isochromatic plates to identify slight anomalous trichromatism.
Birch J
Ophthalmic Physiol Opt; 2010 Sep; 30(5):667-71. PubMed ID: 20883353
[TBL] [Abstract][Full Text] [Related]
7. A pathological indicator for dysthyroid optic neuropathy: tritan color vision deficiency.
Garip Kuebler A; Halfter K; Reznicek L; Klingenstein A; Priglinger S; Rudolph G; Hintschich C
Graefes Arch Clin Exp Ophthalmol; 2021 Nov; 259(11):3421-3426. PubMed ID: 34159407
[TBL] [Abstract][Full Text] [Related]
8. A multifactorial screening model based on the Graves ophthalmopathy quality of life scores in dysthyroid optic neuropathy.
Liang JQ; Tian P; Fan SX; Zhou C; Zhou SY; Wang M; Zeng P
Graefes Arch Clin Exp Ophthalmol; 2024 Jun; ():. PubMed ID: 38910153
[TBL] [Abstract][Full Text] [Related]
9. Clinical use of the American Optical Company (Hardy, Rand and Rittler) pseudoisochromatic plates for red-green colour deficiency.
Birch J
Ophthalmic Physiol Opt; 1997 May; 17(3):248-54. PubMed ID: 9196667
[TBL] [Abstract][Full Text] [Related]
10. Clinical color vision testing and correlation with visual function.
Zhao J; Davé SB; Wang J; Subramanian PS
Am J Ophthalmol; 2015 Sep; 160(3):547-552.e1. PubMed ID: 26116263
[TBL] [Abstract][Full Text] [Related]
11. Utility of isolated-check visual evoked potential technique in dysthyroid optic neuropathy.
Luo B; Liu R; Wang S; Hu W; Li Y; Tong B; Zhang H; Qi X
Graefes Arch Clin Exp Ophthalmol; 2023 Jul; 261(7):2031-2040. PubMed ID: 36642765
[TBL] [Abstract][Full Text] [Related]
12. The new Richmond HRR pseudoisochromatic test for colour vision is better than the Ishihara test.
Cole BL; Lian KY; Lakkis C
Clin Exp Optom; 2006 Mar; 89(2):73-80. PubMed ID: 16494609
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the new web-based "Colour Assessment and Diagnosis" test.
Seshadri J; Christensen J; Lakshminarayanan V; Bassi CJ
Optom Vis Sci; 2005 Oct; 82(10):882-5. PubMed ID: 16276319
[TBL] [Abstract][Full Text] [Related]
14. Clinical features of dysthyroid optic neuropathy: a European Group on Graves' Orbitopathy (EUGOGO) survey.
McKeag D; Lane C; Lazarus JH; Baldeschi L; Boboridis K; Dickinson AJ; Hullo AI; Kahaly G; Krassas G; Marcocci C; Marinò M; Mourits MP; Nardi M; Neoh C; Orgiazzi J; Perros P; Pinchera A; Pitz S; Prummel MF; Sartini MS; Wiersinga WM;
Br J Ophthalmol; 2007 Apr; 91(4):455-8. PubMed ID: 17035276
[TBL] [Abstract][Full Text] [Related]
15. Combination Model of Thyrotrophin Receptor Antibody and Volumetric Orbital Apex Crowding Index as an Indicator of Dysthyroid Optic Neuropathy.
Deng Z; Chen L; Tan J; Wang S; Liu D; Wang J; Jiang C; Yang J; Xu B
Dis Markers; 2021; 2021():9964232. PubMed ID: 34113406
[TBL] [Abstract][Full Text] [Related]
16. Accuracy of four commonly used color vision tests in the identification of cone disorders.
Thiadens AA; Hoyng CB; Polling JR; Bernaerts-Biskop R; van den Born LI; Klaver CC
Ophthalmic Epidemiol; 2013 Apr; 20(2):114-21. PubMed ID: 23510316
[TBL] [Abstract][Full Text] [Related]
17. Optical coherence tomography measurements in compressive optic neuropathy associated with dysthyroid orbitopathy.
Park KA; Kim YD; In Woo K; Kee C; Han JC
Graefes Arch Clin Exp Ophthalmol; 2016 Aug; 254(8):1617-1624. PubMed ID: 27169807
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of Color Vision Deficiency in an Adult Population in South Korea.
Kim H; Ng JS
Optom Vis Sci; 2019 Nov; 96(11):866-873. PubMed ID: 31688694
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic methods for dysthyroid optic neuropathy: A systematic review and analysis.
Sio SWC; Chan BKT; Aljufairi FMAA; Sebastian JU; Lai KKH; Tham CCY; Pang CP; Chong KKL
Surv Ophthalmol; 2024; 69(3):403-410. PubMed ID: 38007201
[TBL] [Abstract][Full Text] [Related]
20. Complete recovery of visual acuity as the main goal of treatment in patients with dysthyroid optic neuropathy.
Miśkiewicz P; Rutkowska B; Jabłońska A; Krzeski A; Trautsolt-Jeziorska K; Kęcik D; Milczarek-Banach J; Pirko-Kotela K; Samsel A; Bednarczuk T
Endokrynol Pol; 2016; 67(2):166-73. PubMed ID: 26884288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
